|
PPP1R11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.31892324523642E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.45110043373131E-10 |
| Normal-vs-Stage2 |
1.07209999999913E-06 |
| Normal-vs-Stage3 |
5.41350297922349E-11 |
| Normal-vs-Stage4 |
3.4567999573909E-09 |
| Stage1-vs-Stage2 |
7.916600E-01 |
| Stage1-vs-Stage3 |
7.419800E-02 |
| Stage1-vs-Stage4 |
3.918000E-01 |
| Stage2-vs-Stage3 |
3.603000E-01 |
| Stage2-vs-Stage4 |
7.232200E-01 |
| Stage3-vs-Stage4 |
5.087600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.79899461783384E-11 |
| Normal-vs-AfricanAmerican |
4.244800E-04 |
| Normal-vs-Asian |
2.03939999998681E-07 |
| Caucasian-vs-AfricanAmerican |
5.924400E-01 |
| Caucasian-vs-Asian |
6.604400E-01 |
| AfricanAmerican-vs-Asian |
8.222800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.81889972370197E-10 |
| Normal-vs-Female |
2.89069879144677E-11 |
| Male-vs-Female |
8.573400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.61220004013529E-09 |
| Normal-vs-Age(41-60Yrs) |
1.65739999502534E-09 |
| Normal-vs-Age(61-80Yrs) |
2.97609714650093E-11 |
| Normal-vs-Age(81-100Yrs) |
1.046290E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.807400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.002430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.322200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.127800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.564400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.300200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.493900E-02 |
| Classical-VS-Follicular |
6.056500E-03 |
| Classical-VS-Other |
8.917000E-01 |
| Classical-VS-Normal |
1.79619996654168E-09 |
| Tall-VS-Follicular |
7.659400E-01 |
| Tall-VS-Other |
5.229800E-01 |
| Tall-VS-Normal |
2.46950000004631E-07 |
| Follicular-VS-Other |
3.080200E-01 |
| Follicular-VS-Normal |
3.71599973014725E-10 |
| Other-VS-Normal |
5.725900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86920035005755E-10 |
| Normal-vs-N1 |
1.407596261771E-11 |
| N0-vs-N1 |
1.102410E-01 |
|
|
